Drug Trial Radar · NCT07325526
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Feb 27, 2026
Primary completion
Aug 5, 2027
Study completion Aug 5, 2027
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Jan 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults with a type of confirmed liver condition called compensated cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH). The purpose of this study is to find out how well a study medicine called BI 3802876 is tolerated in people with this condition. The study looks at how different doses of BI 3802876 are handled by the body. BI 3802876 is being developed to improve liver health in people living with this liver condition. Participants are put in 3 different dose groups randomly, which means by chance. Participants within a group get BI 3802876 or placebo. Placebo looks like BI 3802876 but does not contain any medicine. Participants have more than twice the chance of receiving BI 3802876 than placebo. The study medicine is given as an infusion into a vein. Participants are in the study for about half a year. During this time, they visit the study site 12 times. At 2 visits, participants get the study medicine. Doctors collect information on any health problems and take blood samples to check how BI 3802876 is handled by the body. They compare results between the groups.
Conditions
- Liver Cirrhosis
Interventions
BI 3802876Drug
BI 3802876
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of any Adverse Events (AEs)Time frame: up to 134 days
Locations
28 sites in 2 countries. Site status is shown where the registry gives one.
Arizona Clinical Trials - Chandler
Chandler, Arizona · Recruiting
Southern California Research Center
Coronado, California · Recruiting
Velocity Clinical Research, San Diego
La Mesa, California · Recruiting
Kaiser Permanente - Los Angeles Medical Center
Los Angeles, California · Recruiting
Catalina Research Institute, LLC
Montclair, California · Recruiting
Peak Gastroenterology Associates
Colorado Springs, Colorado · Recruiting
Mayo Clinic
Jacksonville, Florida · Recruiting
Schiff Center Liver Diseases
Miami, Florida · Recruiting
Panax Clinical Research
Miami Lakes, Florida · Recruiting
Covenant Metabolic Specialists, LLC - University Park
University Park, Florida · Recruiting
Centricity Research Columbus Georgia Multispecialty
Columbus, Georgia · Recruiting
University of Iowa Hospitals and Clinics
Iowa City, Iowa · Recruiting
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
Johns Hopkins Hospital
Baltimore, Maryland · Not yet recruiting
Mayo Clinic, Rochester
Rochester, Minnesota · Recruiting
Columbia University Medical Center
New York, New York · Recruiting
Lucas Research, Inc.
Morehead City, North Carolina · Recruiting
Medical University of South Carolina
Charleston, South Carolina · Recruiting
Nashville General Hospital
Nashville, Tennessee · Recruiting
Texas Clinical Research Institute, LLC
Arlington, Texas · Recruiting
Epic Medical Research - Carrollton
Carrollton, Texas · Recruiting
The Liver Institute at Methodist Dallas
Dallas, Texas · Recruiting
Baylor Scott & White Research Institute
Dallas, Texas · Not yet recruiting
Epic Medical Research - Fort Worth
Fort Worth, Texas · Recruiting
Houston Methodist Hospital
Houston, Texas · Recruiting
Pioneer Research Solutions, Inc.
Houston, Texas · Recruiting
American Research Corporation at the Texas Liver Institute
San Antonio, Texas · Recruiting
University of Alberta Hospital (University of Alberta)
Edmonton, Alberta, Canada · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.